Exosome RNA Exosome RNA Research & Industry News
Pleural mesothelioma (PM) is a rare and aggressive cancer that typically affects the lining of the lungs. Unfortunately, early detection of PM remains a significant challenge, primarily because current biomarkers lack sensitivity, and screening options are limited. However, recent research has started to explore extracellular vesicles (EVs) as potential biomarkers for a range of diseases, including cancer. These tiny particles, which are released from cells, contain various types of RNA and proteins that reflect the state of the originating cells. In this study, scientists at the University Hospital Zurich investigated whether EVs could be used to detect pleural mesothelioma at an earlier stage by analyzing the RNA found inside them.
Study overview
Extracellular vesicles (EVs) were isolated from cell culture supernatant of four pleural mesothelioma (PM) cell cultures and profiled using RNA sequencing. The transcriptomic profiles of these EVs were compared to publicly available gene expression data from EVs isolated from 32 healthy plasma samples. Genes expressed in pleural mesothelioma-derived EVs (PM-EVs) were further linked to pleural mesothelioma-specific transcriptional compartments, and the enrichment of cancer hallmarks within PM-EVs was characterized
To conduct the study, the researchers collected cell culture supernatants (the liquid part of the culture) from PM cells grown in the laboratory. These cells were obtained from the pleural effusion of patients with PM. After isolating the EVs from these supernatants, the team extracted and sequenced the RNA content to identify which types of RNA were present in the vesicles. They found a variety of RNA species, including protein-coding RNA, long non-coding RNA (which doesn’t code for proteins but plays other roles in gene regulation), pseudogenes, and short non-coding RNA.
One key discovery was that the RNA cargo in the PM-EVs included genes that are associated with two molecular subtypes of PM: epithelioid and sarcomatoid. These are two types of tumor cell characteristics seen in mesothelioma that could be important for diagnosis. When comparing the RNA content of PM-EVs to EVs from healthy donors, the researchers found that many of the genes upregulated in PM-EVs were linked to these molecular subtypes, making them potential markers for detecting the cancer.
Further analysis also revealed that the RNA in the PM-EVs was linked to processes like epithelial-mesenchymal transition (a biological process often associated with cancer spread), glycolysis (a form of energy production used by rapidly growing cancer cells), and hypoxia (low oxygen levels that are common in tumors). These findings suggest that the RNA found in EVs could not only serve as a biomarker for early detection but might also provide insights into the biological processes driving the disease.
In conclusion, this study marks an important step forward in the search for effective early detection methods for pleural mesothelioma. By identifying the RNA profile in EVs secreted by PM cells, these researchers have opened the door to potential blood-based tests for this challenging disease. Further research into the functional roles of these EVs will be crucial in understanding PM better and developing new therapeutic approaches.
